What was the prescribed dosage?
advertisement

Here is the some steps to help you to save money on Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day purchase.


Read drug prescription

It is very important to know about what medicine is given by the doctor, for what condition, and when it needs to be taken in what dose. This information given by the doctor is called Prescription. The patients should be familiar with the medicine prescription, and the details about the medicine before purchasing it and using it. Some medications need not be prescribed by healthcare practitioners and can be purchased and used without prescription by the patients; these are called over-the-counter medications. Read the drug prescription information of Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day before taking it.

What is Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day is an antiviral medication.
Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C.
Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day may also be used for purposes not listed in Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day guide.

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day and call your doctor at once if you have a serious side effect such as:

Less serious side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
advertisement

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day dosing

Usual Adult Dose for Chronic Hepatitis C:

CAPSULES, ORAL SOLUTION:
In combination with peginterferon alfa-2b:
Less than 66 kg: 400 mg orally twice a day
66 to 80 kg: 400 mg orally in the morning and 600 mg in the evening
81 to 105 kg: 600 mg orally twice a day
Greater than 105 kg: 600 mg orally in the morning and 800 mg in the evening
Duration of therapy:
-Interferon alpha-naive patients with genotype 1: 48 weeks
-Interferon alpha-naive patients with genotype 2 and 3: 24 weeks
-Retreatment with peginterferon alfa-2b/ribavirin of prior treatment failures: 48 weeks, regardless of HCV genotype
In combination with interferon alfa-2b:
75 kg or less: 400 mg orally in the morning and 600 mg in the evening
Greater than 75 kg: 600 mg orally twice a day
Duration of therapy:
-Interferon alpha-naive patients: 24 to 48 weeks
-Retreatment with interferon alfa-2b/ribavirin in patients who relapse after nonpegylated interferon monotherapy: 24 weeks
Comments:
-The manufacturer's product information for peginterferon alfa-2b or interferon alfa-2b should be consulted.
-Combination therapy with peginterferon alfa-2b is preferred; provides substantially better response rates than combination therapy with interferon alfa-2b.
-Patients with previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and/or genotype 1 infection are less likely to benefit from retreatment after a failing course of therapy.
Approved indication: In combination with peginterferon alfa-2b or interferon alfa-2b, for treatment of chronic hepatitis C in patients with compensated liver disease
TABLETS:
In combination with peginterferon alfa-2a:
-Genotypes 1 and 4 in patients less than 75 kg: 1000 mg/day orally in 2 divided doses for 48 weeks
-Genotypes 1 and 4 in patients 75 kg or more: 1200 mg/day orally in 2 divided doses for 48 weeks
-Genotypes 2 and 3: 800 mg/day orally in 2 divided doses for 24 weeks
-Genotypes 5 and 6: Insufficient data to make a recommendation
-In patients coinfected with HIV: 800 mg/day orally in 2 divided doses for 48 weeks, regardless of HCV genotype
Comments:
-The manufacturer's product information for peginterferon alfa-2a should be consulted.
Approved indication: In combination with peginterferon alfa-2a, for treatment of patients with chronic hepatitis C who have compensated liver disease and have not been previously treated with interferon alfa

Usual Adult Dose for Respiratory Syncytial Virus:

Case Review: One vial (6 g) dissolved and delivered through a Small Particle Aerosol Generator (SPAG-2) over a continuous 22-hour period, daily for 5 consecutive days

Usual Pediatric Dose for Respiratory Syncytial Virus:

20 mg/mL as the starting solution in the drug reservoir of the SPAG-2 unit, with continuous aerosol administration for 12 to 18 hours per day for 3 to 7 days
Comments:
-The operator's manual for the SPAG-2 should be consulted.
-Using 20 mg/mL, the aerosol concentration for a 12-hour delivery period averages 190 mcg/L of air.
-Ribavirin should not be administered simultaneously or combined with any other aerosolized medications.
-Sudden deterioration of respiratory function has been associated with initiation of Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day inhalation therapy in infants; careful monitoring of respiratory function during therapy recommended. If initiation of inhaled Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day produces sudden deterioration of respiratory function, therapy should be discontinued and restarted only with extreme caution, continuous monitoring, and coadministration of bronchodilators should be considered.
Approved indication: For treatment of hospitalized infants and young children with severe lower respiratory tract infections due to respiratory syncytial virus

Usual Pediatric Dose for Chronic Hepatitis C:

CAPSULES, ORAL SOLUTION:
3 years or older:
In combination with peginterferon alfa-2b or interferon alfa-2b: 15 mg/kg orally per day in 2 divided doses
Ribasphere RibaPak 1200 Dose Pack, 600 MG 7 Day dosages according to weight:
Less than 47 kg: 15 mg/kg (oral solution) orally per day in 2 divided doses
47 to 59 kg: 400 mg orally twice a day
60 to 73 kg: 400 mg orally in the morning and 600 mg in the evening
Greater than 73 kg: 600 mg orally twice a day
Duration of therapy:
-Genotype 1: 48 weeks
-Genotypes 2 and 3: 24 weeks
Comments:
-The manufacturer's product information for peginterferon alfa-2b or interferon alfa-2b should be consulted.
-Combination therapy with peginterferon alfa-2b is preferred; provides substantially better response rates than combination therapy with interferon alfa-2b.
-Patients who reach their 18th birthday while receiving peginterferon alfa-2b plus Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day should remain on the pediatric dosing regimen.
-Patients with previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and/or genotype 1 infection are less likely to benefit from retreatment after a failing course of therapy.
Approved indication: In combination with peginterferon alfa-2b or interferon alfa-2b, for treatment of chronic hepatitis C in patients with compensated liver disease
TABLETS:
5 years or older:
In combination with peginterferon alfa-2a:
23 to 33 kg: 200 mg orally twice a day
34 to 46 kg: 200 mg orally in the morning and 400 mg in the evening
47 to 59 kg: 400 mg orally twice a day
60 to 74 kg: 400 mg orally in the morning and 600 mg in the evening
75 kg or more: 600 mg orally twice a day
Duration of therapy:
-Genotype 2 and 3: 24 weeks
-Other genotypes: 48 weeks
Comments:
-The manufacturer's product information for peginterferon alfa-2a should be consulted.
-Patients who reach their 18th birthday while receiving peginterferon alfa-2a plus Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day should remain on the pediatric dosing regimen.
Approved indication: In combination with peginterferon alfa-2a, for treatment of patients with chronic hepatitis C who have compensated liver disease and have not been previously treated with interferon alfa

Select the most affordable brand or generic drug

Generic drug is the basic drug with an active substance in it, and the name of the generic drug is same as active substance most of the times. Like Acetaminophen/Paracetemol is Generic name and it has different brand names like Tylenol, Acimol, Crocin, Calpol etc. All these Brand names contain the same Paracetemol, but the medications are manufactured by different companies, so the different brand names. Generic drug is always cheaper and affordable, and it can be replaced in place of brand name drug prescribed by the healthcare practitioner. The Generic medicine has same properties as branded medicine in terms of uses, indications, doses, side effects, so no need to worry on that. Just select the most affordable generic or branded medicine.

StrengthQuantityPrice, USDCountry
40 mg/ml100 ml$192.10Barbados, Canada, NZ, UK
40 mg/ml100 ml$192.10Barbados, Canada, NZ, UK
40 mg/ml300 ml$516.30Barbados, Canada, NZ, UK
RIBAVIN Capsule/ Tablet / 200mg (4 units) $3.13Lupin Laboratories
Ribavin 200mg Capsule $1.09Lupin Ltd
200 mg40 $205.00Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
200 mg42 $163.00Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK, USA
200 mg70 $291.00Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK
Ribavirin 200 mg capsule $10.33
Rebetol 40 mg/ml Solution $2.42
Ribavirin powder $3.21
RIBAVIRIN cap 200 mg x 40's $11.20Mepro
100 mg4 Tablet$1.59
200 mg x 4's $3.16
50 mg x 5 mL x 30ml $1.14
Viron 10 x 10's $6.51
advertisement

References

  1. Dailymed."Ribavirin: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
  2. "Ribavirin". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  3. "Ribavirin". http://www.drugbank.ca/drugs/DB0081... (accessed August 28, 2018).

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day - Frequently asked Questions

Can Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

What other drugs will affect Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day?

Tell your doctor about all other medicines you use, especially:

This list is not complete and other drugs may interact with Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

Who should not take Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day?

You should not take Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day if you are allergic to it, or if you have:

To make sure you can safely take Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day, tell your doctor if you have any of these other conditions:

This medication can cause birth defects or death in an unborn baby.

Your name may need to be listed on a Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day pregnancy registry if you become pregnant while you or your male sexual partner are taking this medication or during the 6 months after treatment ends. This is to track the outcome of the pregnancy and to evaluate any effects of Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day on the baby.

It is not known whether Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are taking Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day.

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day may affect growth in children.

How should I take Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day?

Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day is not effective when used alone to treat hepatitis C. It must be used together with an interferon alfa product (such as Peg-Intron or Intron A) to treat chronic hepatitis C.

Take this medicine with food.

Measure the liquid form of Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day may decrease the number of red blood cells in your body. This is called anemia and it can be life-threatening in people who have heart disease or circulation problems. Your blood will need to be tested often. Your vision, liver function, and thyroid function may also need to be tested. Visit your doctor regularly.

Call your doctor at once if you have pale or yellowed skin, dark colored urine, fever, confusion, chest pain, shortness of breath, or weakness. These may be signs of serious anemia.

Use Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

Drink extra fluids while you are taking Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day to keep from getting dehydrated, especially during exercise or in hot weather.

Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day can cause dry mouth, which could lead to tooth decay or gum disease. If you vomit while taking Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day, rinse your mouth out with water to prevent damage to your teeth or gums. Be sure to have regular dental exams while you are taking this medication.

Store Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day tablets and capsules at room temperature away from moisture, heat, and light.

Store Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day liquid (oral solution) in the refrigerator. Do not allow it to freeze.

Can Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

advertisement

Reviews

Following the study conducted by gmedication.com on Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Ribasphere RibaPak 1200 Dose Pack, 600 MG (14) 7 Day. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reported useful

No survey data has been collected yet


Patient reported side effects

No survey data has been collected yet


Patient reported price estimates

No survey data has been collected yet


Patient reported frequency of use

No survey data has been collected yet


Patient reported doses

No survey data has been collected yet


Patient reported time for results

No survey data has been collected yet


Patient reported administration

No survey data has been collected yet


Patient reported age

No survey data has been collected yet


Patient reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 29 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology